151 related articles for article (PubMed ID: 16407714)
1. Lifestyle intervention to prevent diabetes: intensive and cost effective.
Wylie-Rosett J; Herman WH; Goldberg RB
Curr Opin Lipidol; 2006 Feb; 17(1):37-44. PubMed ID: 16407714
[TBL] [Abstract][Full Text] [Related]
2. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
Eddy DM; Schlessinger L; Kahn R
Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program.
Sathish T; Oldenburg B; Thankappan KR; Absetz P; Shaw JE; Tapp RJ; Zimmet PZ; Balachandran S; Shetty SS; Aziz Z; Mahal A
BMC Med; 2020 Sep; 18(1):251. PubMed ID: 32883279
[TBL] [Abstract][Full Text] [Related]
5. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes.
Diabetes Prevention Program Research Group
Diabetes Care; 2003 Sep; 26(9):2518-23. PubMed ID: 12941712
[TBL] [Abstract][Full Text] [Related]
6. Lifestyle interventions for diabetes mellitus type 2 prevention.
Sagarra R; Costa B; Cabré JJ; Solà-Morales O; Barrio F;
Rev Clin Esp (Barc); 2014 Mar; 214(2):59-68. PubMed ID: 24267869
[TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
8. Cost of a group translation of the Diabetes Prevention Program: Healthy Living Partnerships to Prevent Diabetes.
Lawlor MS; Blackwell CS; Isom SP; Katula JA; Vitolins MZ; Morgan TM; Goff DC
Am J Prev Med; 2013 Apr; 44(4 Suppl 4):S381-9. PubMed ID: 23498303
[TBL] [Abstract][Full Text] [Related]
9. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance.
Wong CK; Jiao FF; Siu SC; Fung CS; Fong DY; Wong KW; Yu EY; Lo YY; Lam CL
J Diabetes Res; 2016; 2016():1219581. PubMed ID: 26798647
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the PREDICE project: cost-effectiveness of type 2 diabetes prevention among high-risk Spanish individuals following lifestyle intervention in real-life primary care setting.
Costa B; Cabré JJ; Sagarra R; Solà-Morales O; Barrio F; Piñol JL; Cos X; Bolíbar B; Castell C; Kissimova-Skarbek K; Tuomilehto J;
BMC Public Health; 2011 Aug; 11():623. PubMed ID: 21831332
[TBL] [Abstract][Full Text] [Related]
12. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis.
Glechner A; Keuchel L; Affengruber L; Titscher V; Sommer I; Matyas N; Wagner G; Kien C; Klerings I; Gartlehner G
Prim Care Diabetes; 2018 Oct; 12(5):393-408. PubMed ID: 30076075
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials.
Yoon U; Kwok LL; Magkidis A
Metabolism; 2013 Feb; 62(2):303-14. PubMed ID: 22959500
[TBL] [Abstract][Full Text] [Related]
14. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.
Li G; Zhang P; Wang J; Gregg EW; Yang W; Gong Q; Li H; Li H; Jiang Y; An Y; Shuai Y; Zhang B; Zhang J; Thompson TJ; Gerzoff RB; Roglic G; Hu Y; Bennett PH
Lancet; 2008 May; 371(9626):1783-9. PubMed ID: 18502303
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of the Da Qing diabetes prevention program: A modelling study.
Hu W; Xu W; Si L; Wang C; Jiang Q; Wang L; Cutler H
PLoS One; 2020; 15(12):e0242962. PubMed ID: 33382746
[TBL] [Abstract][Full Text] [Related]
16. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.
Palmer AJ; Roze S; Valentine WJ; Spinas GA; Shaw JE; Zimmet PZ
Clin Ther; 2004 Feb; 26(2):304-21. PubMed ID: 15038953
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
Trials; 2015 Nov; 16():496. PubMed ID: 26530718
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.
Caro JJ; Getsios D; Caro I; Klittich WS; O'Brien JA
Diabet Med; 2004 Nov; 21(11):1229-36. PubMed ID: 15498090
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of a lifestyle intervention in preventing Type 2 diabetes.
Irvine L; Barton GR; Gasper AV; Murray N; Clark A; Scarpello T; Sampson M
Int J Technol Assess Health Care; 2011 Oct; 27(4):275-82. PubMed ID: 22004767
[TBL] [Abstract][Full Text] [Related]
20. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]